Quincy Bioscience Earns NSF Good Manufacturing Practice (GMP) Registration for Facilities

Prevagen Producer Is Pleased to Report Manufacturing Facility Is Now NSF Registered. End Quote

Madison, WI (1888PressRelease) July 19, 2013 - Quincy Bioscience announced today that its Pinehurst manufacturing facility is now a Good Manufacturing Practices (GMP) facility registered by NSF International.

Earning GMP registration from NSF International verifies that Quincy Bioscience's facility has the proper methods, equipment, facilities, and controls in place for producing dietary supplement products. The NSF GMP's were developed in accordance with the U.S. Food and Drug Administration's (FDA) 21 CFR part 111 regulation on dietary supplement manufacturing, packaging, and distribution. Utilizing GMP guidelines assists companies in developing and maintaining proper controls in their manufacturing process so that products are processed, manufactured and labeled in a consistent manner, and meet quality standards.

"Earning NSF GMP registration for their Pinehurst manufacturing facility provides Quincy Bioscience with a system for continual improvement, as well as demonstrates to customers and supply chain partners their commitment to quality and safety," said Ed Wyszumiala, General Manager of NSF International's Dietary Supplement programs.

"We're proud to achieve this recognition of our manufacturing facilities," says Mark Underwood, President of Quincy Bioscience. "We take good manufacturing practices very seriously, and we look forward to continuing our practice of excellence."

Quincy Bioscience manufactures Prevagen, the #1 selling brain health supplement in chain drug pharmacies. Prevagen contains the main ingredient 'apoaequorin', a protein originally discovered in a jellyfish which is used to improve mild memory loss associated with aging.

For more information about Quincy Bioscience, please visit the website.

About Quincy Bioscience:
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin focused on the discovery, development and commercialization of novel technologies to support good health in aging. The company's products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

###

space

Other Related Press Releases